ViraCor offers the broadest spectrum of quantitative PCR and immunological assays for the most important infectious diseases affecting immunocompromised patients. Our results are reliable and our service is unequaled for every test.
Assay Design
Uniquely designed assays validated for immunocompromised patients by accounting for all strains, serotypes, and clinical isolates
False negative results avoided via dual-gene targets in each assay
Assays actively monitored and targets refined to account for new strains or mutations
Wide dynamic assay range for increased result accuracy and clinical relevance
Quantitative results let clinicians monitor infection and ongoing effectiveness of therapy
Precision and Consistency
Optimized extraction methods achieve highest sensitivity and maximum pathogen yields
Quantitation extensively validated across entire assay range, as well as validation for shipping and specimen types
Low coefficients of variation ensure assay consistency over time
Internal amplification controls ensure proper extraction and alert presence of PCR inhibitors
Each specimen run in duplicate
Service
Ambient shipping eliminates unnecessary, time-consuming, and costly steps
Test results within 24 hours
Patient’s result history included with lab report
Results via web, fax, interface, or phone to multiple locations
Knowledgeable staff scientists available to answer your questions
ViraCor offers the broadest spectrum of quantitative PCR and immunological assays for the most important infectious diseases affecting immunocompromised patients. Our results are reliable and our service is unequaled for every test.